Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
Due to our interest in the chemical space of organic dyes to identify potential small-molecule inhibitors (SMIs) for protein-protein interactions (PPIs), we initiated a screen of such compounds to assess their inhibitory activity against the interaction between SARS-CoV-2 spike protein and its cogna...
Main Authors: | Damir Bojadzic, Oscar Alcazar, Peter Buchwald |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.600372/full |
Similar Items
-
Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
by: Sung-Ting Chuang, et al.
Published: (2022-05-01) -
Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40–CD154 Costimulatory Protein-Protein Interaction
by: Damir Bojadzic, et al.
Published: (2018-05-01) -
Removal of Methylene Blue by Crosslinked Egg White Protein/Graphene Oxide Bionanocomposite Aerogels
by: Yonghui Jin, et al.
Published: (2022-08-01) -
In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2
by: Mathieu Gendrot, et al.
Published: (2021-07-01) -
Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
by: Riadh Badraoui, et al.
Published: (2021-01-01)